DERM — Journey Medical Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1867066 ·
Last close
$6.37
Market Cap
$137.18M
52W High
$7.45
52W Low
$4.83
ADV30
271,093
Next earnings
2026-08-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 15,961,000 | 9,743,000 | -1,492,000 | -2,230,000 | 91,534,000 | 27,219,000 | 60,703,000 |
| Dec 2025 | 16,079,000 | 10,639,000 | -443,000 | -1,247,000 | 94,589,000 | 24,090,000 | 62,737,000 |
| Sep 2025 | 17,631,000 | 11,876,000 | -1,529,000 | -2,315,000 | 85,191,000 | 24,948,000 | 59,293,000 |
| Jun 2025 | 15,009,000 | 10,070,000 | -2,876,000 | -3,796,000 | 81,158,000 | 20,293,000 | 61,912,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,700,000
Investing CF
$-15,000,000
Financing CF
$12,849,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.51
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-100,688,000
Inventory
$9,292,000
Receivables
$24,992,000
ST Investments
—
EBIT TTM
$-5,829,000
Pretax Income TTM
$-9,528,000
Interest Exp TTM
$3,699,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$64,680,000
EBITDA
$-2,021,000
Free Cash Flow
$-3,300,375
Enterprise Value
$173,643,072
Total Cash
$27,219,000
Total Debt
$25,467,000
Shares Out
21,534,547
Trailing EPS
$-0.37
Book Value
$1.13
ROE
-36.6%
ROA
-4.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,858,000 | -8,172,000 | -11,431,000 | 94,589,000 | 62,737,000 | — | -12,441,000 |
| Dec 2024 | 56,134,000 | -18,230,000 | -14,672,000 | 80,241,000 | 60,172,000 | — | -9,127,000 |
| Dec 2023 | 79,181,000 | 1,070,000 | -3,853,000 | 76,849,000 | 56,499,000 | — | 5,240,000 |
| Dec 2022 | 73,669,000 | -27,517,000 | -29,628,000 | 105,160,000 | 88,178,000 | — | -13,534,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.06
Max Pain — expiry 2026-08-21
max pain strike: $7.50 · spot: $6.37 · call oi: 1,160 · put oi: 5
Expected Move to 2026-08-21:
±$1.30
(20.41%) —
implied range
$5.07 –
$7.67
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UNCY | Unicycive Therapeutics, Inc. | $137.24M | $5.01 | — |
| HURA | TuHURA Biosciences, Inc./NV | $138.19M | $2.17 | — |
| MIST | Milestone Pharmaceuticals Inc. | $138.19M | $1.11 | — |
| EQ | Equillium, Inc. | $139.10M | $2.20 | — |
| NRXP | NRX Pharmaceuticals, Inc. | $134.82M | $3.15 | — |
News headlines (Yahoo Finance, 1h cache)
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
2026-06-25 04:29 · Yahoo
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target
2026-06-03 22:07 · Yahoo
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
2026-05-19 20:45 · Yahoo
Journey Medical Corporation Q1 2026 Earnings Call Summary
2026-05-15 00:25 · Yahoo
Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
2026-05-14 05:01 · Yahoo
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings
2026-05-13 22:30 · Yahoo
Journey Medical (DERM) Q1 2026 Earnings Transcript
2026-05-13 21:55 · Yahoo
Transcript: Journey Medical Q1 2026 Earnings Conference Call
2026-05-13 21:17 · Yahoo
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
2026-05-13 21:15 · Yahoo
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
2026-05-13 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.